These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 16731602)
1. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. Mrena J; Wiksten JP; Nordling S; Kokkola A; Ristimäki A; Haglund C J Clin Pathol; 2006 Jun; 59(6):618-23. PubMed ID: 16731602 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer. Alakus H; Grass G; Hennecken JK; Bollschweiler E; Schulte C; Drebber U; Baldus SE; Metzger R; Hölscher AH; Mönig SP Histol Histopathol; 2008 Aug; 23(8):917-23. PubMed ID: 18498066 [TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer. Chu D; Zhang Z; Li Y; Zheng J; Dong G; Wang W; Ji G Int J Cancer; 2011 Aug; 129(4):887-95. PubMed ID: 20957628 [TBL] [Abstract][Full Text] [Related]
4. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Zheng HC; Takahashi H; Murai Y; Cui ZG; Nomoto K; Miwa S; Tsuneyama K; Takano Y Br J Cancer; 2006 Nov; 95(10):1371-8. PubMed ID: 17088917 [TBL] [Abstract][Full Text] [Related]
5. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer. Fanelli MF; Chinen LT; Begnami MD; Costa WL; Fregnami JH; Soares FA; Montagnini AL Histopathology; 2012 Aug; 61(2):153-61. PubMed ID: 22582975 [TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression. Lee LY; Wu CM; Wang CC; Yu JS; Liang Y; Huang KH; Lo CH; Hwang TL Histol Histopathol; 2008 May; 23(5):515-21. PubMed ID: 18283635 [TBL] [Abstract][Full Text] [Related]
7. Correlation of COX-2 and MMP-13 expressions with gastric cancer and their effects on prognosis. Ren J; Liu J; Sui X J BUON; 2019; 24(1):187-193. PubMed ID: 30941969 [TBL] [Abstract][Full Text] [Related]
8. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer. Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771 [TBL] [Abstract][Full Text] [Related]
9. Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer. Linder N; Haglund C; Lundin M; Nordling S; Ristimäki A; Kokkola A; Mrena J; Wiksten JP; Lundin J J Clin Pathol; 2006 Sep; 59(9):965-71. PubMed ID: 16935971 [TBL] [Abstract][Full Text] [Related]
11. Expression of Vav3 protein and its prognostic value in patients with gastric cancer. Tan B; Li Y; Shi X; Fan L; Zhao Q; Liu Y; Tan M; Liu Q; Jia N Pathol Res Pract; 2017 May; 213(5):435-440. PubMed ID: 28285969 [TBL] [Abstract][Full Text] [Related]
12. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer. Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533 [TBL] [Abstract][Full Text] [Related]
13. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy. Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis. Joo YE; Oh WT; Rew JS; Park CS; Choi SK; Kim SJ Digestion; 2002; 66(4):222-9. PubMed ID: 12592098 [TBL] [Abstract][Full Text] [Related]
15. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Niwa H; Tsuneyama K; Takano Y Anticancer Res; 2006; 26(5A):3579-83. PubMed ID: 17094486 [TBL] [Abstract][Full Text] [Related]
16. Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer. Byun JH; Lee MA; Roh SY; Shim BY; Hong SH; Ko YH; Ko SJ; Woo IS; Kang JH; Hong YS; Lee KS; Lee AW; Park GS; Lee KY Jpn J Clin Oncol; 2006 May; 36(5):263-8. PubMed ID: 16735371 [TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis. Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052 [TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer. Shao W; Wang W; Xiong XG; Cao C; Yan TD; Chen G; Chen H; Yin W; Liu J; Gu Y; Mo M; He J J Surg Oncol; 2011 Dec; 104(7):841-6. PubMed ID: 21721010 [TBL] [Abstract][Full Text] [Related]
19. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer. Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108 [TBL] [Abstract][Full Text] [Related]
20. [Expression of LOX and MMP-2 in gastric cancer tissue and the effects of LOX and MMP-2 on tumor invasion and metastasis]. Ma LJ; Li YG; Huang L; Han M; Ma BJ; Sun BJ; Lin JJ; Song TG Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):37-41. PubMed ID: 21575462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]